$0.14
0.00% yesterday
Nasdaq, Aug 11, 07:18 pm CET
ISIN
US09057N2018
Symbol
BPTH

Bio-Path Holdings, Inc. Stock price

$0.14
-0.03 16.67% 1M
-0.63 81.79% 6M
-1.02 87.93% YTD
-1.17 89.31% 1Y
-82.66 99.83% 3Y
-76.86 99.82% 5Y
-4,879.86 100.00% 10Y
-2,399.86 99.99% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.00 0.00%
ISIN
US09057N2018
Symbol
BPTH
Industry

Key metrics

Basic
Market capitalization
$1.2m
Enterprise Value
$600.0k
Net debt
positive
Cash
$560.0k
Shares outstanding
3.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
13.7%
Return on Equity
-3,645.8%
ROCE
3,024.4%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-12.4m | -
EBIT
$-12.4m | $-12.3m
Net Income
$-10.5m | $-12.0m
Free Cash Flow
$-9.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
26.1% | -
EBIT
26.2% | 22.6%
Net Income
37.0% | 25.4%
Free Cash Flow
35.4%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-3.5
FCF per Share
$-2.6
Short interest
1.4%
Employees
10
Rev per Employee
$0.0
Show more

Is Bio-Path Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Bio-Path Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Bio-Path Holdings, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Bio-Path Holdings, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Bio-Path Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.65 4.65
1% 1%
-
- Research and Development Expense 7.75 7.75
36% 36%
-
-12 -12
26% 26%
-
- Depreciation and Amortization 0.05 0.05
44% 44%
-
EBIT (Operating Income) EBIT -12 -12
26% 26%
-
Net Profit -11 -11
37% 37%
-

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Path Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Path Holdings, Inc. Stock News

Neutral
GlobeNewsWire
2 months ago
Highlights Promise of DNAbilize® Platform to Produce New Drug Candidates and Potential Licensing Opportunities Highlights Promise of DNAbilize® Platform to Produce New Drug Candidates and Potential Licensing Opportunities
Neutral
GlobeNewsWire
3 months ago
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced that it will host a live conference call and audio webcast on Thursday, May 29, 2025 at 8:30 a.m. ET to provide a comprehensiv...
Neutral
GlobeNewsWire
3 months ago
Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells
More Bio-Path Holdings, Inc. News

Company Profile

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.

Head office United States
CEO Peter Nielsen
Employees 10
Founded 2007
Website www.biopathholdings.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today